SCHEMBL23618320

SCHEMBL23618320

c1ccc(Nc2cccc3cccc(-c4ccccc4)c23)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.53
HSD17B10 Q99714 3/20 0.53
TSHR P16473 2/20 0.53
ATM Q13315 2/20 0.53
TP53 P04637 1/20 0.53
CYP3A4 P08684 1/20 0.53
HPGD P15428 1/20 0.53
ALOX15 P16050 1/20 0.53
CDC25B P30305 1/20 0.53
MAPK14 Q16539 2/20 0.53
FABP4 P15090 2/20 0.53
TTR P02766 1/20 0.53
CCNA2 P20248 1/20 0.53
CDK2 P24941 1/20 0.53
NR4A1 P22736 1/20 0.51
FABP1 P07148 1/20 0.49
MAPT P10636 6/20 0.49
MEN1 O00255 5/20 0.49
KMT2A Q03164 5/20 0.49
MAPK1 P28482 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23618348 0.96 ALDH1A1 (0.50) ALDH1A1HSD17B10TSHRATMTP53
SCHEMBL22112870 0.89 FABP4 (0.44) ALDH1A1HSD17B10TSHRATMTP53
SCHEMBL26557563 0.83 ALDH1A1 (0.50) ALDH1A1HSD17B10TSHRATMTP53
SCHEMBL26557616 0.83 ALDH1A1 (0.44) ALDH1A1HSD17B10TSHRATMTP53
SCHEMBL26768114 0.82 ALDH1A1 (0.64) ALDH1A1HSD17B10TSHRATMTP53
SCHEMBL24945456 0.81 MAPK1 (0.49) ALDH1A1HSD17B10TSHRATMTP53
SCHEMBL27012235 0.81 ALDH1A1 (0.48) ALDH1A1HSD17B10TSHRATMTP53
SCHEMBL26768156 0.80 ALDH1A1 (0.52) ALDH1A1HSD17B10TSHRATMTP53
SCHEMBL29372518 0.80 FABP4 (0.55) ALDH1A1HSD17B10TSHRATMTP53
Benzene SCHEMBL28417037 0.80 FABP4 (0.55) ALDH1A1HSD17B10TSHRATMTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230200224-A1 NITROGEN-CONTAINING COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE HAVING SAME SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-06-22 US disclosed
US-20230200224-A1 NITROGEN-CONTAINING COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE HAVING SAME SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-06-22 US disclosed
WO-2021135542-A1 NITROGEN-CONTAINING COMPOUND, ELECTRONIC ELEMENT, AND ELECTRONIC DEVICE 陕西莱特光电材料股份有限公司 2021-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230200224-A1 NITROGEN-CONTAINING COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE HAVING SAME MNS1, NPM1, NOM1 ALDH1A1 2799/4885HSD17B10 4477/4885TSHR 4376/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.